Comparative study of stemness characteristics of mesenchymal cells from bone marrow of children and adults

References

• Prockop DJ. Marrow stromal cells as stem cells for nonhemaopoietic tissues. Science. 1997;276:71–4.
   PubMed Web of Science ®Google Scholar
• Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Moscka JD, . Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143–7.
   PubMed Web of Science ®Google Scholar
• Caplan AI, Bruder SP. Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends Mol Med. 2001;7:259–64.
   PubMed Web of Science ®Google Scholar
• D'Ippolito G, Schiller PC, Ricordi C, Roos BA, Howard GA. Age-related osteogenic potential of mesenchymal stromal cells from human vertebral bone marrow. J Bone Miner Res. 1999;14:1115–22.
   PubMed Web of Science ®Google Scholar
• Zhou S, Greenberger JS, Epperly MW, Goff JP, Adler C, LeBoff MS, . Age related intrinsic changes in human bone marrow derived mesenchymal stem cells and their differentiation to osteoblasts. Aging Cells. 2008;7:335–43.
   PubMed Web of Science ®Google Scholar
• Mareschi K, Ferrero I, Rustichelli D, Aschero S, Gammaitoni L, Aglietta M, . Expansion of mesenchymal stem cells isolated from pediatric and adult donor bone marrow. J Cell Biochem. 2006;97:744–54.
   PubMed Web of Science ®Google Scholar
• Sethe S, Scutt A, Stolzing A. Aging of mesenchymal stem cells. Ageing Res Rev. 2006;5:91–116.
   PubMed Web of Science ®Google Scholar
• Stolzing A, Jones E, McGonagle D, Scutt A. Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies. Mech Ageing Dev. 2008;129:163–73.
   PubMed Web of Science ®Google Scholar
• Vulliamy T, Marrone A, Goldman F, Dearlove A, Bessler M, Mason PJ, . The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenital. Nature. 2001;413:432–5.
   PubMed Web of Science ®Google Scholar
• Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM. Evidence of mitotic clock in hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci USA. 1994;91: 9857–60.
   PubMed Web of Science ®Google Scholar
• d'Adda di Fagagna F, Reaper PM, Clay-Farrace L, Fiegler H, Carr P, Von Zglinicki T, . A DNA damage checkpoint response in telomere-initiated senescence. Nature. 2003;426: 194–8.
   PubMed Web of Science ®Google Scholar
• Liedtke S, Stephan M, Kogler G. Oct-4 expression revisited: potential pitfalls for data misinterpretation in stem cell research. Biol Chem. 2008;389:845–50.
   PubMedGoogle Scholar
• Guillot PV, Gotherstrom C, Chan J, Kurata H, Fisk NM. Human first-trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC. Stem Cells. 2007;25:646–54.
   PubMed Web of Science ®Google Scholar
• Zangrossi S, Marabese M, Broggini M, Giordano R, D'Erasmo M, Montelatici E, . Oct-4 expression in adult human differentiated cells challenges its role as a pure stem cell marker. Stem Cells. 2007;25:1675–80.
   Google Scholar
• Mitsui K, Tokuzawa Y, Itoh H, Segawa K, Murakami M, Takahashi K, . The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell. 2003;113:631–42.
   PubMed Web of Science ®Google Scholar
• Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, . International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010;115:168–86.
   PubMed Web of Science ®Google Scholar
• Dinauer MC, Newburger PE. The phagocyte system and disorders of Granulopoiesis and Granulocyte function. Orkin SH, Fisher DE, Look AT, Lux SE IV, Ginsburg D, Nathan DG. Nathan and Oski's Hematology of Infancy and Childhood. 7th Philadelphia: Saunders/Elsevier; 2009. 1147–52.
   Google Scholar
• Dimitriou H, Linardakis E, Martimianaki G, Stiakaki E, Perdikogianni CH, Charbord P, . Properties and potential of bone marrow mesenchymal stromal cells from children with hematologic diseases. Cytotherapy. 2008; 10:125–33.
   PubMed Web of Science ®Google Scholar
• Dimitriou H, Perdikogianni C, Martimianaki G, Choumerianou DM, Pelagiadis J, Kalmanti M. Are mesenchymal stromal cells from children resistant to apoptosis? Cell Prolif. 2009;42:276–83.
   PubMedGoogle Scholar
• Pelagiadis I, Dimitriou H, Kalmanti M. Biologic characteristics of mesenchymal stromal cells and their clinical applications in pediatric patients. J Pediatr Hematol Oncol. 2008; 30:301–9.
   PubMedGoogle Scholar
• Granero-Molto F, Weis JA, Longobardi L, Spagnoli A. Role of mesenchymal stem cells in regenerative medicine: application to bone and cartilage repair. Expert Opin Biol Ther. 2008;8:255–68.
   PubMed Web of Science ®Google Scholar
• Ozawa K, Sato K, Oh I, Ozaki K, Uchibori R, Obara Y, . Cell and gene therapy using mesenchymal stem cells (MSCs). J Autoimmun. 2008;30:121–7.
   PubMed Web of Science ®Google Scholar
• Yen BL, Chien CC, Chen YC, Chen JT, Huang JS, Lee FK, . Placenta-derived multipotent cells differentiate into neuronal and glial cells in vitro. Tissue Eng A. 2008;14:9–17.
   PubMed Web of Science ®Google Scholar
• Tsai MS, Lee JL, Chang YJ, Hwang SM. Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Hum Reprod. 2004;19:1450–6.
   PubMed Web of Science ®Google Scholar
• in't Anker PS, Noort WA, Scherjon SA, Kleijburg-van der Keur C, Kruisselbrink AB, van Bezooijen RL, . Mesenchymal stem cells in human second-trimester bone marrow, liver lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. Hematologica. 2003;88:845–52.
   PubMed Web of Science ®Google Scholar
• De la Fuente J, O'Donoghue K, Kumar S, Chan J, Fisk NM, Roberts IA. Ontogeny-related changes in integrin expression and cytokine production by fetal mesenchymal stem cells (MSC). Blood. 2002;v 100:526a.
   Google Scholar
• Perdikogianni C, Dimitriou H, Stiakaki E, Martimianaki G, Kalmanti M. Could cord blood be a source of mesenchymal stromal cells for clinical use? Cytotherapy. 2008;10:452–9.
   PubMed Web of Science ®Google Scholar
• Banfi A, Bianchi G, Notaro R, Luzzatto L, Cancedda R, Quarto R. Replicative aging and gene expression in long term cultures of human marrow stromal cells. Tissue Eng. 2002;8: 901–10.
   PubMedGoogle Scholar
• Humphrey RK, Beattie GM, Lopez AD, Bucay N, King CC, Firpo MT, . Maintenance of pluripotency in human embryonic stem cells is STAT3 independent. Stem Cells. 2004;22:522–30.
   PubMed Web of Science ®Google Scholar
• Pain D, Chirn G, Strassel C, Kemp DM. Multiple retropseudogenes from pluripotent cell-specific gene expression indicates a potential signature for novel gene identification. J Biol Chem. 2005;280:6265–8.
   Google Scholar
• Choumerianou DM, Dimitriou H, Perdikogianni C, Martimianaki G, Riminucci M, Kalmanti M. Study of oncogenic transformation in ex vivo expanded mesenchymal cells from bone marrow of children. Cell Prolif. 2008;41:909–22.
   PubMed Web of Science ®Google Scholar
• Baxter MA, Wynn RF, Jowitt SN, Wraith JE, Fairbairn LJ, Bellantuono I. Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Stem Cells. 2004;22:675–82.
   PubMed Web of Science ®Google Scholar